Empowering biopharma innovation through strategic Business Development. We bridge the gap between global discoveries and market realization.
Founded in August 2025, Neurospan Agent stands at the forefront of the global biopharmaceutical landscape. We are dedicated to simplifying the complexities of cross-border BD transactions.
Our mission is to facilitate seamless collaboration between global innovators and market leaders. By leveraging deep industry expertise and AI-driven insights, we ensure that groundbreaking therapies reach patients faster and more efficiently.
Connecting East & West markets
Data-driven deal sourcing
A unique synergy of deep pharmaceutical expertise and cutting-edge artificial intelligence.
CEO & Founder
Former Senior AI Expert at Alibaba Cloud and ByteDance. Aaron brings world-class expertise in Artificial Intelligence and Big Data, driving the technological backbone of Neurospan's transaction matching algorithms.
COO, Co-founder & Chief Scientist
PhD from Tsinghua University, MBA from Peking University. A veteran Senior Pharmaceutical BD executive. Li bridges the gap between scientific innovation and commercial value, ensuring high-quality asset evaluation.
Real-time analysis of cross-border out-licensing deals.
Sep 01, 2025
Analyzing the recent surge in Antibody-Drug Conjugate transactions across North America and Asia-Pacific markets...
Aug 28, 2025
Latest breakdown of Central Nervous System therapy licensing deals between domestic biotech and European mid-cap pharma...
Aug 15, 2025
How the latest regulatory changes in the US are influencing innovation premiums and BD strategies for Asian originators...
